KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 5,950.00
+210.00 (3.66%)
At close: Apr 1, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 115.54 billion as of April 1, 2026. Its market cap has increased by 26.35% in one year.
Market Cap
115.54B
Enterprise Value
99.17B
Revenue
69.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,950.00
Market Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 115.54B, a decrease of -76.57%. That is a compound annual growth rate of -23.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 115.54B | 3.84% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QuadMedicine | 151.56B |
| BIO-FD&C | 121.13B |
| NovMetaPharma | 110.82B |
| ViGenCell | 110.08B |
| CORESTEMCHEMON | 105.36B |
| TegoScience | 101.60B |
| Cell Biotech | 98.14B |
| Quratis | 97.75B |